New promising research results and extension of on-going studies
Preliminary results from studies conducted in collaboration with VibroSense Dynamics AB (VibroSense) research network indicate that the company's instruments and technology have a high potential for detecting early neurological changes in diabetes and the treatment of cancer with chemotherapy. The company's product thus takes an important step to become part of the therapy in these areas.VibroSense has a dedicated strategy to conduct research in close collaboration with research partners to build a comprehensive virtual research portfolio. The strategy is based on a proprietary technology